BioCentury
ARTICLE | Company News

Bioject, Merck KGaA deal

October 15, 2007 7:00 AM UTC

Under a three-year deal, BJCT will supply its cool.click and Serojet spring-powered needle-free device for use with MRK's Merck Serono S.A. unit's recombinant human growth hormone (hGH) drugs. Fina...